Search results - ORA - Oxford University Research Archive

1 - 10 of 10

1

Conference item

Proteomic evaluation of Pip6a-PMO treatment for myotonic dystrophy type 1

Holland, A, Varela, M, Hazell, G, et al.
2018-04-30

2

Journal article

Cell-penetrating peptide conjugates of steric blocking oligonucleotides as therapeutics for neuromuscular diseases from a historical perspective to current prospects of treatment

Gait, M, Arzumanov, A, McClorey, G, et al.
2018-10-16

3

Conference item

PPMO's as therapeutic modulators for myotonic dystrophy type 1

Holland, A, Varela, M, Klein, A, et al.
2018-09-19

4

Journal article

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice.

Yin, H, Saleh, A, Betts, C, et al.
2011-07-01

5

Journal article

Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment.

Betts, C, Saleh, A, Arzumanov, A, et al.
2012-01-01

6

Journal article

PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation.

Ezzat, K, Andaloussi, SE, Zaghloul, E, et al.
2011-07-01

7

Conference item

NOVEL CELL PENETRATING PEPTIDES FOR SKELETAL AND CARDIAC MUSCLE DELIVERY OF PMO ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Hammond, S, Yin, H, Saleh, A, et al.
2011-10-01

8

Journal article

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice

Yin, H, Saleh, A, Betts, C, et al.
2011-07-01

9

Journal article

Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice

Klein, AF, Varela-Muino, MA, Arandel, L, et al.
2019-09-03

10

Journal article

Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle.

Ivanova, G, Arzumanov, A, Abes, R, et al.
2008-11-01

TO TOP